NASDAQ:HOLX

Hologic Stock Forecast, Price & News

$75.74
-0.09 (-0.12 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$75.29
$76.15
50-Day Range
$60.52
$75.83
52-Week Range
$56.81
$85.00
Volume1.68 million shs
Average Volume2.27 million shs
Market Capitalization$19.20 billion
P/E Ratio9.71
Dividend YieldN/A
Beta1.16
30 days | 90 days | 365 days | Advanced Chart
Receive HOLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.


Hologic logo

About Hologic

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.63 out of 5 stars

Medical Sector

61st out of 1,309 stocks

X-Ray Apparatus & Tubes Industry

1st out of 5 stocks

Analyst Opinion: 3.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Hologic (NASDAQ:HOLX) Frequently Asked Questions

Is Hologic a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Hologic stock.
View analyst ratings for Hologic
or view top-rated stocks.

What stocks does MarketBeat like better than Hologic?

Wall Street analysts have given Hologic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hologic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Hologic's next earnings date?

Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Hologic
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) announced its quarterly earnings data on Wednesday, July, 28th. The medical equipment provider reported $1.33 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.12 by $0.21. Hologic had a net margin of 35.98% and a trailing twelve-month return on equity of 67.74%. During the same quarter last year, the business earned $0.75 earnings per share.
View Hologic's earnings history
.

How has Hologic's stock price been impacted by Coronavirus?

Hologic's stock was trading at $43.78 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HOLX stock has increased by 73.0% and is now trading at $75.74.
View which stocks have been most impacted by COVID-19
.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its fourth quarter 2021 earnings guidance on Wednesday, July, 28th. The company provided earnings per share (EPS) guidance of $0.920-$1.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.130. The company issued revenue guidance of $1 billion-$1.04 billion, compared to the consensus revenue estimate of $1.04 billion.

What price target have analysts set for HOLX?

12 Wall Street analysts have issued twelve-month target prices for Hologic's stock. Their forecasts range from $75.00 to $100.00. On average, they anticipate Hologic's share price to reach $86.93 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price.
View analysts' price targets for Hologic
or view top-rated stocks among Wall Street analysts.

Who are Hologic's key executives?

Hologic's management team includes the following people:
  • Mr. Stephen P. MacMillan, Chairman, CEO & Pres (Age 57, Pay $4.76M)
  • Ms. Karleen M. Oberton, Chief Financial Officer (Age 51, Pay $1.45M)
  • Mr. John M. Griffin, Gen. Counsel (Age 60, Pay $1.38M)
  • Mr. Kevin R. Thornal, Division Pres of Diagnostic Solutions (Age 47, Pay $1.88M)
  • Dr. Jay A. Stein, Co-Founder, Chairman Emeritus, CTO & Sr. VP (Age 78)
  • Mr. Michael J. Watts, VP of Investor Relations & Corp. Communications
  • Ms. Allison P. Bebo, Sr. VP of HR (Age 52)
  • Mr. Jan Verstreken, Group Pres of International
  • Ms. Monica Aguirre Berthelot, Chief of Staff
  • Mr. Mike Kelly, Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs

What is Steve MacMillan's approval rating as Hologic's CEO?

283 employees have rated Hologic CEO Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among Hologic's employees.

Who are some of Hologic's key competitors?

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), The Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by many different retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.52%), Vaughan Nelson Investment Management L.P. (0.31%), PGGM Investments (0.18%), State of Michigan Retirement System (0.16%), Alliancebernstein L.P. (0.15%) and New York State Common Retirement Fund (0.15%). Company insiders that own Hologic stock include Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends for Hologic
.

Which institutional investors are selling Hologic stock?

HOLX stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Victory Capital Management Inc., New York State Common Retirement Fund, PGGM Investments, Dupont Capital Management Corp, Oregon Public Employees Retirement Fund, Advisor Group Holdings Inc., and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Kevin R Thornal, and Sean S Daugherty.
View insider buying and selling activity for Hologic
or view top insider-selling stocks.

Which institutional investors are buying Hologic stock?

HOLX stock was purchased by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., State of Michigan Retirement System, MUFG Securities EMEA plc, Asymmetry Capital Management L.P., Ellsworth Advisors LLC, Handelsbanken Fonder AB, Hussman Strategic Advisors Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Hologic
or or view top insider-buying stocks.

How do I buy shares of Hologic?

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $75.74.

How much money does Hologic make?

Hologic has a market capitalization of $19.20 billion and generates $3.78 billion in revenue each year. The medical equipment provider earns $1.12 billion in net income (profit) each year or $3.98 on an earnings per share basis.

How many employees does Hologic have?

Hologic employs 5,814 workers across the globe.

Does Hologic have any subsidiaries?

The following companies are subsidiares of Hologic: Focal Therapeutics.

When was Hologic founded?

Hologic was founded in 1985.

What is Hologic's official website?

The official website for Hologic is www.hologic.com.

Where are Hologic's headquarters?

Hologic is headquartered at 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752.

How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-263-2900 or via email at [email protected]


This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.